1992
Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity
Concha M, Graham N, Muñoz A, Vlahov D, Royal W, Updike M, Nance-Sproson T, Seines O, McArthur J. Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity. American Journal Of Epidemiology 1992, 136: 1338-1348. PMID: 1362630, DOI: 10.1093/oxfordjournals.aje.a116446.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsBaltimoreBlack or African AmericanCD4-Positive T-LymphocytesChronic DiseaseCognition DisordersConfounding Factors, EpidemiologicEducational StatusEmploymentEvaluation Studies as TopicFemaleHIV SeropositivityHIV SeroprevalenceHIV-1HumansLeukocyte CountLinear ModelsMaleMass ScreeningNeuropsychological TestsPopulation SurveillancePredictive Value of TestsPrisonsPsychomotor PerformanceSubstance Abuse, IntravenousConceptsNeuropsychological test performanceHIV-1 seropositivityIntravenous drug usersTest performanceNeuropsychological performancePractice effectsHuman immunodeficiency virus type 1 (HIV-1) infectionDrug usersVirus type 1 infectionSubstance abuseSignificant practice effectsHIV-1 serostatusType 1 infectionIntravenous Experience (ALIVE) studyFrequency of drugChronic substance abuseNeuropsychological functioningCognitive performanceImmunodeficiency syndromeAsymptomatic stageHigh prevalenceOutcome measuresDrug useIntoxicated individualsMultivariate analysis
1991
HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users.
Royal W, Updike M, Seines O, Proctor T, Nance-Sproson L, Solomon L, Vlahov D, Cornblath D, McArthur J. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991, 41: 1905-10. PMID: 1745346, DOI: 10.1212/wnl.41.12.1905.Peer-Reviewed Original ResearchConceptsHIV-1 serostatusIntravenous drug usersNeurologic abnormalitiesDrug usersSeronegative intravenous drug usersCD4 cell countHIV-seropositive subjectsHIV-1 infectionNervous system abnormalitiesConstitutional symptomsElectrophysiologic evaluationSeropositive participantsSeropositive subjectsElectrophysiologic abnormalitiesHIV infectionStudy cohortNeurologic diseaseSystem abnormalitiesHomosexual menCell countSerologic groupsCohortAbnormalitiesClear associationNeuropsychological testsSelf-Report Interview Data for a Study of HIV-1 Infection among Intravenous Drug Users: Description of Methods and Preliminary Evidence on Validity
Anthony J, Vlahov D, Celentano D, Menon A, Margolick J, Cohn S, Nelson K, Polk B. Self-Report Interview Data for a Study of HIV-1 Infection among Intravenous Drug Users: Description of Methods and Preliminary Evidence on Validity. Journal Of Drug Issues 1991, 21: 739-757. DOI: 10.1177/002204269102100405.Peer-Reviewed Original ResearchIntravenous drug usersHIV-1 infectionDrug usersDrug useT lymphocyte cell subsetsActive intravenous drug usersSelf-report interview dataHIV-1 serostatusOnset of AIDSPreliminary evidenceCell subsetsDrug injectionBaseline interviewStudy populationCommunity outreach effortsPrior treatmentDrug dependencePhysical stigmataInfectionSelf-reported dataBaltimore CityYear historyInjection equipmentAIDSBaselineUtilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIVRisk factors for shooting gallery use and cessation among intravenous drug users.
Celentano D, Vlahov D, Cohn S, Anthony J, Solomon L, Nelson K. Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal Of Public Health 1991, 81: 1291-5. PMID: 1928528, PMCID: PMC1405311, DOI: 10.2105/ajph.81.10.1291.Peer-Reviewed Original ResearchConceptsIntravenous drug usersActive intravenous drug usersGallery useRisk factorsDrug usersShooting galleriesHIV-1 transmissionHIV-1 serostatusHIV-1 infectionLow socioeconomic statusLifetime attendanceHomosexuality/bisexualityBlack raceMale genderDrug useMultivariate analysisReporting useGallery attendanceSocioeconomic statusDrug involvementCessationHigh-risk environmentsAttendanceSerostatusInfection
1990
ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND
VLAHOV D, MUñOZ A, ANTHONY J, COHN S, CELENTANO D, NELSON K. ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND. American Journal Of Epidemiology 1990, 132: 847-856. PMID: 2239899, DOI: 10.1093/oxfordjournals.aje.a115727.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 seroprevalenceVirus type 1Drug usersInjection careerShooting galleriesType 1Drug injection patternsHIV-1 serostatusHIV-1 infectionRecent onsetDrug injectionHigh riskCommunity outreach effortsDrug useGallery useSame calendar yearSex practicesSeroprevalenceCalendar yearPersistent useAntibodiesPersistent sharingAntibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons
Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah A. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 531-535. DOI: 10.1097/00126334-199003050-00010.Peer-Reviewed Original ResearchHuman T-Lymphotropic Virus Type I/IIExact testIncoming male inmatesHIV-1 serostatusIntravenous drug usersPrevalence of HTLVFisher's exact testYears of ageSame calendar periodWestern blot techniqueType I/IIEpidemiological serosurveyMale inmatesScope of infectionRisk groupsCalendar periodHIV-1Drug usersHTLVMaryland prisonsBlot techniqueRoutine operational proceduresAntibodiesYear of entrySerostatusAntibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons
Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah A. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 531-535. PMID: 1969961, DOI: 10.1097/00126334-199005000-00010.Peer-Reviewed Original ResearchConceptsHuman T-Lymphotropic Virus Type I/IIExact testIncoming male inmatesHIV-1 serostatusIntravenous drug usersPrevalence of HTLVFisher's exact testYears of ageSame calendar periodWestern blot techniqueType I/IIEpidemiological serosurveyScope of infectionMale inmatesCalendar periodRisk groupsHIV-1Drug usersHTLVMaryland prisonsChi 2Blot techniqueRoutine operational proceduresAntibodiesYear of entry